Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits Price Target Forecast with 26.17% Profit Margin

November 30, 2022
ELI LILLY AND COMPANY stock has successfully reached the price target forecast set by QuantWave on 2022-05-06, resulting in a profit margin of 26.17%. The forecast indicated a long position on the stock when it was trading at 288.27 $. The target price of 363.7 $ was achieved on 2022-11-30, validating the accuracy of QuantWave's prediction.

Market analysis suggests that several factors contributed to the movement of ELI LILLY AND COMPANY stock. The pharmaceutical sector experienced growth due to increased demand for healthcare products. Additionally, positive developments in the company's drug pipeline and strong financial performance also played a role in driving the stock price higher.

This successful forecast for ELI LILLY AND COMPANY stock highlights the effectiveness of QuantWave's analytical capabilities. By leveraging data-driven insights and sophisticated algorithms, QuantWave delivers accurate predictions that enable investors to make informed decisions and maximize profits.

QuantWave is a leading automated forecasting platform that provides predictions for a wide range of stocks, offering opportunities for potential profits. For investors interested in refining their investment strategy, QuantSchool offers comprehensive educational resources that outline key principles for generating consistent income using the QuantWave forecasting system.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

REGNApril 8, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target with 20% Profit: QuantWave Analysis  ~1 min.

In a recent success for QuantWave's forecasting platform, the stock of REGENERON PHARMACEUTICALS, INC. has hit its price target with a 20% profit margin....

ABTFebruary 28, 2024ABBOTT LABORATORIES Stock Hits Forecasted Price Target with 13.42% Profit  ~2 min.

On July 18, 2023, QuantWave's forecast signal predicted a long position for ABBOTT LABORATORIES stock when it was trading at $102.80....

PFEJuly 26, 2024Price Target Forecast Success: PFIZER INC. Achieves 14.81% Profit as Predicted by QuantWave  ~1 min.

In a significant win for QuantWave's analytics, the stock of PFIZER INC. has successfully reached the forecasted price target with a profit of 14.81%....

LLYNovember 8, 2022ELI LILLY AND COMPANY Hits Price Target Forecast on QuantWave Platform, Delivering 22.87% Profit  ~2 min.

ELI LILLY AND COMPANY, a pharmaceutical giant, has successfully reached the price target forecast set on the QuantWave platform, resulting in a lucrative profit of 22.87%....

LLYMay 3, 2023ELI LILLY AND COMPANY Stock Hits Forecast Price Target with 19.14% Profit Gain  ~2 min.

ELI LILLY AND COMPANY's stock has successfully achieved the price target forecast set by QuantWave, resulting in a profit gain of 19.14%. The forecast signal was given on January 4, 2023, with a price of 355....